Market Challenges And Opportunities

Global Leptospirosis Market – Driver

Ongoing research and development by key market players

Ongoing research and development for vaccine development against leptospirosis by key market players are expected to drive the global leptospirosis market over the forecast period. For instance, on January 26, 2021, eLife, a non-profit organization created by funders and led by researchers, issued a statement stating that the scientists had designed a single-dose universal vaccine that could protect against the many forms of leptospirosis bacteria. According to a study published in eLife, a peer-reviewed journal, an effective vaccine would help prevent the life-threatening conditions caused by leptospirosis, such as Weil’s disease and lung hemorrhage, which are fatal in 10% and 50% of cases, respectively. In the preclinical study, the data has shown that a universal leptospirosis vaccine candidate can prevent both death and kidney colonization in animal models.

Global Leptospirosis Market: Restraint

Lack of standardization of diagnostic testing and treatment alternatives for the prevention and control of Leptospirosis

Global leptospirosis market growth can be hindered by lack of standardization of diagnostic testing and approved treatment alternatives for the prevention and control of leptospirosis. For instance, on September 22, 2021, According to the data published by the Department Of Health And Mental Hygiene Human cases of leptospirosis, New York City. the staeted that Fourteen people diagnosed with leptospirosis have been reported to date in 2021, more than the total number reported to the New York City Health Department in any prior year. The majority of patients were hospitalized with acute renal and hepatic failure, two of whom also had severe pulmonary involvement. Leptospirosis is treated with antibiotics, such as doxycycline or penicillin, which should be given early in the course of the disease.

Thus it is required to focus on research and development activities for the development of drugs indicated for the treatment of Leptospirosis